India is looking at greater market access for its pharmaceutical products in the UK as part of the proposed free trade agreement with Britain, an official said on Friday. The official also said that a leaked chapter of the agreement, which is floated on some portals, on intellectual property (IP) is edited, distorted, and is a manipulated version of an initial document of the UK.
“The best part in the proposed agreement is that both sides have highlighted their red lines and sensitivities.
Ever-greening and touching manufacturing of generic medicines is completely non-negotiable,” the official added.
India has already secured greater market access for the domestic pharma industry in a trade pact with the UAE.